Article
Genentech rides up to 2nd target in Bicycle immuno-oncology collab
Rating:
0.0
Views:
45
Likes:
1
Library:
1
Roche's Genentech unit called in an option to license a second immuno-oncology target from its collaboration with British biotech Bicycle Therapeutics. | Roche's Genentech unit called in an option to license a second immuno-oncology target from its collaboration with British biotech Bicycle.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value